Clik here to view.
Temasek invests $800m, inks partnership deal with Verily
Verily Life Sciences, the medical arm of Google parent Alphabet (NSDQ:GOOGL), said today Singapore-based investment company Temasek invested $800 million as part of a partnership deal. As part of the...
View ArticleClik here to view.
JDRF backs Bigfoot Biomedical with equity investment
The Juvenile Diabetes Research Foundation said today that its T1D Fund made an unspecified equity investment in Bigfoot Biomedical and the Smartloop automated insulin delivery system it’s developing....
View ArticleClik here to view.
Johnson & Johnson’s earnings disappoint, but pharma rev climbs
Shares in Johnson & Johnson (NYSE:JNJ) fell this week after the company missed the consensus top-line forecasts but pulled off earnings beats for both the 4th quarter and 2016. Pharmaceutical sales...
View ArticleClik here to view.
Avinger touts 2-year Pantheris study data
Avinger (NSDQ:AVGR) today released 2-year interim data from the pivotal Vision trial of its Pantheris system, touting high rates of freedom from target lesion revascularization. The study aimed to...
View ArticleClik here to view.
Philips, Bon Secours Charity Health ink $180m, multi-year deal
Royal Philips (NYSE:PHG) and Westchester Medical Center Health Network’s Bon Secours Charity Health System said today that they signed a multi-year strategic partnership worth $180 million, aiming to...
View ArticleClik here to view.
Medrobotics raises $20m for Flex system
Medrobotics, which developed the Flex robot-assisted surgery platform, said in a regulatory filing today that it raised some $20 million in an equity round. The Raynham, Mass.-based company won...
View ArticleClik here to view.
Endo cuts staff in restructuring effort
Endo International (NSDQ:ENDP) said today that it will cut 90 full-time positions from its workforce in an effort to restructure its generics and U.S. branded pharmaceutical businesses. The company...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 26, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
DePuy Synthes wins FDA nod for Viper, Expedium pedicle screw systems
Johnson & Johnson (NYSE:JNJ) business DePuy Synthes said today it won FDA 510(k) clearance for its Viper and Expedium fenestrated screw systems intended to restore spinal column integrity in...
View ArticleClik here to view.
Spinal disc replacement maker Axiomed raises $1m
Spinal device developer Axiomed has raised $1 million in a new round of equity financing, according to an SEC filing posted this week. The Malden, Mass.-based company produces the Freedom cervical disc...
View ArticleClik here to view.
Trump and medtech: What people in the industry think
Many MassDevice and Medical Design & Outsourcing readers think permanent medical device tax repeal should be a top priority for President Donald Trump and the Republican Congress. Many say the new...
View ArticleClik here to view.
This AI can spot skin cancer as well as doctors
A dermatologist uses a handheld microscope called a dermatoscope to examine skin lesions. Stanford University researchers think a new AI developed could potentially provide another layer of screening....
View ArticleClik here to view.
Celgene acquires Delinia, beats on Q4 earnings
Shares in Celgene (NSDQ:CELG) fell yesterday, even though the biopharmaceutical company beat earnings expectations on Wall Street with its 4th quarter results. The Summit, N.J.-based company posted...
View ArticleClik here to view.
C.R. Bard’s Q4 sales, earnings beat estimates
C.R. Bard (NYSE:BCR) beat the consensus forecast with its 4th-quarter results yesterday, with both sales and earnings growing at a double-digit clip. The Murray Hill, N.J.-based healthcare giant posted...
View ArticleClik here to view.
Judge pares $20m verdict in doc’s patent spat with Medtronic
A federal judge in Texas reduced a $20.3 million verdict against Medtronic (NYSE:MDT) by $2.6 million this week, ruling that Dr. Mark Barry did not present sufficient evidence that the company...
View ArticleClik here to view.
Appeals court upholds $3m verdict against J&J’s Ethicon in pelvic mesh case
A federal appeals court yesterday upheld a $3.3 million verdict against Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon in a product liability lawsuit brought over its TVT-O pelvic mesh. A jury in...
View ArticleClik here to view.
AirXpanders lands $34m private placement
AirXpanders (ASX:AXP) said today that it has commitments from investors in a private placement to raise A$45 million, or $34 million USD. The Palo Alto, Calif.-based company said that its investors...
View ArticleClik here to view.
BioVentrix raises $8m
BioVentrix raised $7.9 million in a new offering of convertible notes, according to an SEC filing. BioVentrix produces the Revivent TC transcatheter ventricular enhancement system designed to treat the...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 27, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Presbia prices $13.5m rights offering
Presbia (NSDQ:LENS) today priced an upcoming rights offering, looking to offer up to 4.5 million shares at $3 per share, netting the company as much as $13.5 million. The offering will go out to...
View Article